ScreenerHero

ACTIActive Biotech AB (publ)

STO · SE · Healthcare · Biotechnology · activebiotech.com
5.300SEK0.00%Mkt Cap: 13.36M $P/E: —

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small m…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap13.36M $
Enterprise Value7.92M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.57M $
Revenue/Share—
Last Price5.300 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.13
EV/EBITDA-2.48
EV/Revenue—
P/S—
P/B2.50
EPS (TTM)-2.21
EPS (Forward)0.00
52W Range
3.7009% of range22.00
52W High22.00 SEK
52W Low3.700 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-67.11%
ROA-53.16%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.10M $
CapEx (TTM)—
FCF Margin—
FCF Yield-13.64%
Net Debt-5.09M $
Net Debt/EBITDA1.59
Balance Sheet
Debt/Equity0.03
Current Ratio5.14
Quick Ratio5.14
Book Value/Sh2.110 SEK
Cash/Share2.022 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJun 3, 2026
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)25.00 SEK
Upside (mean)+371.7%
Target Range25.00 SEK – 25.00 SEK
# Analysts1
Ownership
Shares Out.26.36M
Float20.47M
Insiders16.99%
Institutions6.33%
Technical
SMA 505.470 (-3.1%)
SMA 2005.383 (-1.6%)
Beta1.34
S&P 52W Chg18.16%
Avg Vol (30d)49.68K
Avg Vol (10d)53.03K
Technical Indicators
RSI (14)49.3
MACD-0.0638
MACD Signal-0.0872
MACD Hist.+0.0234
BB Upper5.423 SEK
BB Middle5.235 SEK
BB Lower5.047 SEK
BB Width7.20%
ATR (14)0.2343 SEK
Vol Ratio (20d)0.37x